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Abstract
Background: Methamphetamine abuse is a worldwide health concern. Methamphetamine causes health hazards in
many vital organs. It can cause damage to cardiac tissue via catecholamines release. Methamphetamine related
deaths are becoming one of the most important problems in Iran. The purpose of the present study was to determine
cardiac pathology in methamphetamine poisoning-related deaths.
Methods: The study included 100 cases of methamphetamine poisoning-related deaths and 100 cases as control
group. Toxicology analysis of liver, gastric content, bile, urine, blood and vitreous humor were conducted to detect
drugs, poisons and alcohols using thin layer chromatography, gas chromatography/mass spectrometry, and high
performance liquid chromatography. Positive toxicology analysis results except for amphetamine and methamphetamine
were excluded from the study in order to omit interfering factors. The most striking features of cardiac damage were
observed by light microscopy.
Results: Methamphetamine and amphetamine were detected in either urine or gastric content samples. In all of the
cases methamphetamine toxicity was determined to be a direct cause of death by forensic medicine practitioner.
Cardiovascular pathology was noted in 68% of studied cases. The most common histopathologic features were
myocardial fiber hypertrophy, mild, moderate to severe atherosclerosis and focal degeneration/necrosis.
Conclusion: The results of the present study indicate that cardiotoxicity is one of the major contributing factors
in methamphetamine poisoning related deaths. Overall, the current study highlights the fact that cardiotoxic effects of
methamphetamine can explain increasing reports of heart failure and consequently death in young abusers.
Trial registration: Not applicable.
Keywords: Methamphetamine poisoning-related death, Cardiac histopathology, Forensic toxicology, Forensic
pathology, Forensic medicine
Background
Amphetamine type stimulants (ATS) are indirect sym-
pathomimetic drugs that have been widely used to in-
crease mood. Abuse of methamphetamine (MA) is a
growing social problem all over the world. According to
the World Drug Report, the global market for synthetic
drugs continues to be dominated by MA. This report
stated that Iran ranked fifth in MA seizure after Mexico,
United States of America, China and Thailand [1]. This
synthetic stimulant drug can be produced from inexpen-
sive precursors. MA low cost production and long
duration of action makes it an illegal substance with
high abuse potential [2]. MA with the street name of
“Shishe” has high prevalence of abuse in different popu-
lation groups in Iran. MA high rate of domestic produc-
tion and seizure confirms its widespread use. Although
MA clandestine laboratories started illicit production
since 1980s in Texas and some other countries [3], it
was seized first in Iran since 2005. Till now it had been
popular in young adults for different purposes. Polysub-
stance abusers, body builders and women use MA for
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increasing physical and social activities, enhancement of
sexual performance and weight loss [4].
MA exerts its stimulant effect by induction of sympa-
thetic nervous system activity and catecholamine over-
flow. It causes several central nervous and cardiovascular
systems adverse effects through coronary vasoconstriction
and the production of oxygen free radicals [5, 6]. MA
causes a large number of problems in vital organs and no
organ in the body remains unscathed by MA and its im-
purities [7]. Methamphetamine associated cardiomyop-
athy appears to be genetically dependent. Cytochrome
p450 polymorphism is responsible for different grades of
MA-induced cardiomyopathy. Individuals who are
CYP2D6 extensive metabolizers are significantly vulner-
able to MA-induced cardiomyopathy [8].
Alghamahdi et al. in a study conducted on patients ad-
mitted to a medical center in Saudi Arabia, found that
the majority of cases with amphetamine abuse history
showed cardiomyopathy, myocarditis and arrhythmia
[6]. Kaye et al. showed coronary artery atherosclerosis,
cardiomegaly and ventricular hypertrophy in MDMA
(3,4- methylendioxymethamphetamine “ecstasy”) abusers
in Australia [9]. Sadeghi et al. showed cardiomyopathy
and congestive heart failure in three MA abuser cases
admitted to Loghman Hakim Hospital, Tehran, Iran
[10]. In a retrospective clinical study Wijetunga et al. re-
ported that MA appears to produce cardiomyopathy in
some users [11]. Previous case reports showed congestive
cardiomyopathy, focal coagulation necrosis in myocar-
dium, right ventricular rupture and arrhythmia in MA
abusers who died of heart failure [5, 12, 13].
In spite of the introduction of novel psychoactive sub-
stances to drug black market all over the world, MA is
the most abused substance in some African, American
and Asian countries [2]. Therefore MA effect on vital or-
gans has drawn a great deal of attention. MA abuse has
appeared a new health problem in Iran [4]. Although
there are many studies about psychiatric effects of ATS
and their clinical complications in patients admitted to
medical centers and also their adverse effects in experi-
mental animal models, few reports exists on the histo-
pathologic cardiac effects of MA abuse in forensic cases
in Iranian population.
The aim of the present work was to study the toxicology




A total of 100 MA poisoning-related deaths occurring
in Tehran, Iran with the age range of 21–35 years
(young adult) were sequentially identified and selected
over one year study period (January 1st, 2015 till
December, 30th 2015). In order to reduce bias, all cases
with a history of previous cardiovascular complications
were not included in the present study. As MA abuse is
prevalent in young age ranges, study cases were selected
from this range of ages. Also 100 age and sex-matched
MA negative control group were selected from cases with
no history of substance abuse. The manner of death of
control cases was car accident, falling down or stab
wound. All cases with positive toxicology results for drugs,
alcohols and poisons other than MA were excluded from
the study (56 cases) due to the probable toxicity induced
histopathological changes in selected organs such as heart.
Chemicals and reagents
Methamphetamine hydrochloride (HCl) was purchased
from Lipomed Pharmaceutical (Arlesheim, Switzerland).
Water, n- hexane, n-heptane (high-performance liquid
chromatography (HPLC) grade), formalin, xylol, hema-
toxylin and eosin were purchased from Merck Com-
pany (Germany). Potassium hydroxide (KOH) and
sodium bicarbonate (NaHCO3) were Reagent Plus®,
99.9% and were supplied by Sigma Aldrich (Germany).
Heptafluorobutyric acid (HFBA) in derivatization grade
was obtained from Sigma Aldrich (Germany). Paraffin
was purchased from Sakura Company, Japan.
Toxicology analysis
In situations of unnatural deaths especially in young
cases, qualitative and quantitative toxicological analysis
is necessarily and routinely performed to detect the
cause of death. Samples collected at autopsy examin-
ation are looked for drugs according to the toxicology
laboratory protocols. Thin layer chromatography (TLC),
headspace gas chromatography (HSGC), Agilent 6890 N
(USA) model equipped with flame ionization detector,
with chromatographic column DB-ALC1, capillary
column (30 m × 0.320 mm × 1.8 mm), high performance
liquid chromatography (HPLC) (Knauer, Germany) with
a diode array detector (DAD) (Knauer DAD 2700,
Germany) equipped with a quaternary pump (Knauer
pump 1000, Germany) and gas chromatography (GC)
(Agilent Technologies, sdn Bhd, Selangor) and mass
spectrometry (MS) 5975C model (Agilent Technologies)
were used to perform toxicology tests on liver, urine,
blood, vitreous humor, gastric content and bile. Predeve-
loped method was used to extract MA and amphetamine
(AM) using liquid liquid extraction (LLE) technique.
Urine or stomach content samples were vortexed and
centrifuged for 5 min at 9000 r/min. Separated superna-
tants were transferred into a glass tube. After the
addition of KOH (0.5 M), pH was adjusted to 11–12.
Desired analyte (methamphetamine) was extracted by
adding n-hexane and n-heptane. HFBA was used as
derivatization reagent. Excess amount of HFBA was
deactivated by adding NaHCO3. Organic layer was
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separated and analysed. GC/MS instrumentation was
used to detect MA and AM. The method was fully vali-
dated and showed acceptable intra and inter assay preci-
sion. Limit of detection (LOD) and limit of quantitation
(LOQ) for MA were 5 and 15 ng/mL respectively.
GC method chromatographic conditions were as
following:
Helium (99.999%) with 1.5 mL/min constant flow rate,
inlet temperature 250 °C and injection volume of 1 μL
(splitless) were used. The oven temperature was set at
90 °C (held for 1 min) followed by 20 °C/min ramp to
280 °C and held for 5 min. Mass source and quadrupole
temperatures were set at 230 °C and 150 °C, respectively.
The ion source was operated in full scan and selected
ion monitoring (SIM) mode both together. In full scan
mode, scan range was 40–500 m/z, ions selected for
quantitative analysis were 118 and 254 for MA.
Histologic examination
Histologic examination was performed on cardiac tissue
of MA poisoning-related death cases that had already
been confirmed by analytical toxicology results. The
cause of death of all cases was determined as MA poi-
soning by forensic practitioners.
Pre-established macroscopic and histological criteria
were used for the diagnosis of cardiac pathology. The
histopathological assessment included the inspection of
ventricles, pericardium, endocardium, and coronary
arteries. Each sample was scored histopathologically with
a grade of 0 = negative, 1 =mild (occasional scars), 2 =
moderate (multiple scars), or 3 = severe (extensive) to
evaluate the extent of heart histopathological changes.
Cardiac tissues of 100 control and cases were formalin-
fixed. After fixation, samples were dehydrated in alcohol
series and embedded in paraffin wax in order to be
stained by hematoxylin and eosin and examined under
light microscopy for histopathological study based on
Kiernan protocol [14]. Two pathologists reviewed slides
blindly. Any gross and microscopic features of cardiac
tissue were considered and histologic changes for each
case were recorded.
Statistical analysis
Quantitative variables were expressed as mean ± SD, and
qualitative variables were expressed as percentages.
Descriptive statistics were used to describe the basic fea-
tures of the data in the study. Also logistic regression
analysis was used to determine the association between
MA toxicity and cardiac histology. In order to determine
the effect of some risk factors in general population and
the presence of cardiovascular pathology, multivariate
logistic regression analyses were conducted with inde-
pendent variables such as gender, age and body mass
index (BMI). Results presented as 95% confidence intervals
(CI) and odds ratio (OR). P values < 0.05 and 95% CI which
do not include OR = 1 are considered significant.
Ethics approval and consent to participate
According to Legal Medicine Research Center, Iran’s
ethics Committee, the information about human ca-
davers was fully confidential. Data were anonymously
treated. The project was approved with the registration
number: 1588. The study protocol conformed to the
ethical guidelines of 1975 Declaration of Helsinki, as re-
vised in 1983.
Results
To detect the cardiac histology changes of MA poisoning-
related deaths, we examined biological samples obtained
at autopsy examination from toxicological and pathologic
point of view.
Demographic characteristics
In the present study methamphetamine was noted as
a direct cause of death in all 100 cases. The mean
age (standard deviation) of cases was 28.2 (2.80) years
with the age range of 21–35 years. The majority of cases
were men (95%). Less than 30% of cases were in the treat-
ment program for drug dependence at the time of death.
The mean BMI (standard deviation) of cases was 26.7
(4.32). Males showed significantly higher BMI than
females (p < 0.05).
Toxicological analysis results
Vitreous humor and blood samples were negative for
alcohols (methanol, ethanol and isopropanol). Urine,
liver, gastric content and bile samples were negative for
drugs and poisons other than methamphetamine except
for excluded cases. Methamphetamine and its metabolite,
amphetamine were detected in urine or gastric content
samples. Figures 1 and 2 show chromatogram and mass
spectra of derivatized amphetamine and methampheta-
mine with heptafluorobutyric acid in the urine sample of a
fatal methamphetamine-poisoning related death case.
All of the samples were negative for other conven-
tional, illegal drugs and also poisons.
Noticeable in our study was the high percentage of cases
(56 cases) with multiple drug intoxication (especially
opium alkaloids, methadone, tramadol and ethanol).
These cases were excluded from the study.
Histologic examination results
The gross examination of the heart showed varied from no
structural changes to pattern of dilated cardiomyopathy.
Full autopsy reports of all 100 control and 100 case
subjects were available to the forensic pathologists.
Cardiovascular pathology was noted in 68% of cases.
Some commonly histopathologic feature was
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myocardial fiber hypertrophy (Fig. 3), perivascular fi-
brosis (Fig. 4) and acute myocardial infarction (Fig. 5).
Figure 6 shows the normal cardiac tissue of a control
subject.
Table 1 shows a summary of the main patterns of mor-
phologic cardiac injury in 100 cases of MA poisoning-
related deaths. It should be taken into account that
coexistence of two or three cardiac histology changes in
one case is common.
The presence of cardiac tissue damage however was
not significantly predicted by any of the aftermentioned
variables (age, sex and BMI). Methamphetamine abuse
was significantly associated with cardiovascular path-
ology (95% CI, OR = 1.7, p < 0.05).
Fig. 2 Mass spectra of derivatized amphetamine and methamphetamine with heptafluorobutyric acid detected in the urine sample of a fatal
methamphetamine-poisoning related death case
Fig. 1 Chromatogram of derivatized amphetamine and methamphetamine with heptafluorobutyric acid detected in the urine sample of a fatal
methamphetamine-poisoning related death case
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Discussion
The purpose of the present study was to investigate the
effect of MA on cardiac tissue in MA poisoning-related
death cases. According to the results of the study MA has
contributed to clinically significant histologic changes in
cardiac tissue. MA was a direct cause of death in all
studied cases. These results were consistent with previous
studies in cases of ATS related deaths [9, 15, 16]. Dece-
dents were in the young age range, a demographic profile
similar to other studies [9]. In consistent with the results
of the present study, several epidemiological studies in
Iran demonstrated that more than 90% of illicit drug users
were men [4, 17, 18]. Although MA use treatment pro-
grams have been provided by public and private centers
under the authority of the Ministry of Health and Medical
Education, Iran, less than 30% of our study cases were re-
ferred from these centers. This indicates that in spite of
severe control, abusers have free access to illegal drugs in
treatment centers.
MA poisoning was noted as a direct or antecedent
cause of death. Cardiac histology changes were corre-
lated with MA abuse independent to variables such as
gender, age and BMI. These results are in agreement
with those of Kaye et al. who studied on methylendioxy-
methamphetamine related fatalities in Australia [9].
Methamphetamine can be detected in various bio-
logical matrices in forensic and clinical laboratories [19].
Comprehensive toxicology testing revealed the presence
of no drugs with the exception of MA and AM in all
cases in the present study.
To our knowledge this study is the first to report car-
diac histology changes in MA poisoning-related deaths
in Iranian population except for a few case reports that
had been published in regard to MA induced cardiomy-
opathy in clinical cases not in forensic ones [10, 20, 21].
The present study aimed to address this gap in Iran.
There are genetic variations in metabolism and pharma-
cologic response to drugs. In this regard drug related
Fig. 3 Histopathological section of myocardial fiber hypertrophy in a
methamphetamine poisoning-related death case. Arrow shows scattered
enlarged dark nuclei in hypertrophic myocardial fiber. Hematoxylin and
eosin stain, 40× original magnification
Fig. 4 Interstitial and perivascular fibrosis in myocardium of a methamphetamine poisoning-related death case showed by arrow. Hematoxylin
and eosin stain, 40× original magnification
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deaths could be interpreted with difficulty in forensic
cases [22].
Methamphetamine undergoes three metabolic pathways
in the body: 1) n-demethylation reaction to produce am-
phetamine, 2) aromatic hydroxylation making 4- hydro-
xyamphetamine (pholedrine), 3) beta- hydroxylation
producing norephedrine [23–25]. The polymorphic cyto-
chrome P450 isozyme, CYP2D6 is responsible for the
metabolism of most ATS. Acute toxicity, dependence
and long-term neurotoxicity could be influenced by
CYP2D6 genetics [23]. Catalytic activity of CYP2D6
varies considerably in different populations as a result
of genetic variation. It is assumed that Asian population
are slower in the rate of metabolic disruption of
CYP2D6 substrates, leading to a higher tendency to ac-
cumulate some drugs such as MA in the body [23]. It is
supposed that genetic variation in Iranian population
can cause different responses to MA. Sutter et al. in
their study concluded that the polymorphism in
CYP2D6 enzyme may predict MA-related heart compli-
cations [26].
There are some reports that ATS can cause tissue
damage in vital organs through different mechanisms
[12, 27, 28]. The mechanisms of producing
Fig. 5 Acute myocardial infarction in a methamphetamine poisoning-related death case. Arrows show edema, fiber necrosis and polymorphonuclear
(PMN) infiltration. Hematoxylin and eosin stain, 100× original magnification
Fig. 6 Histologic section of a normal myocardium of a control case. Arrows shows normal muscle fiber and blood vessel. Hematoxylin and eosin
stain, 40× original magnification
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cardiomyopathy in MA animal and human users are
multifactorial. Suggested mechanisms for MA-induced
cardiac injuries are: excess of catecholamines, coronary
vasospasm and ischemia, reactive oxygen species pro-
duction, mitochondrial dysfunction, accelerated apop-
tosis, cardiomyocytes necrosis, defects in intracellular
calcium hemostasis and abnormality in cardiac protein
production [29, 30]. The pattern described in the present
study overlaps with the histological picture seen in pre-
vious studies. Myocardial fiber hypertrophy and myocar-
dial ischemia were seen in 24 and 8% of our cases
respectively. As it is shown in Fig. 3 in hypertrophic car-
diomyocytes nuclei are enlarged. As a consequence of
increased amount of their constituent DNA, appear
hyperchromatic [31]. Ischemia can be seen in hyper-
trophic hearts. In spite of the promotion of
vascularization with expanding muscle mass, oxygen and
nutrients cannot be carried completely through the
microvascular system to reach myocytes. Therefore in
conditions such as exercise, increased heart rate and
arrhythmia, myocardial ischemia may be triggered [12,
27]. It seems likely that hypertrophy is one of the diag-
nostic factors for MA-related deaths from heart failure
[5]. The results mirror exactly those of the Rosenblum
et al. survey, which reported that drugs that can release
heart catecholamines produce cardiac lesions in experi-
mental animal models. Chronic elevation of catechol-
amines causes cardiac remodeling and also hypertrophy
and fibrosis [32]. Positive inotropic (amphetamines) and
chronotropic substances increase oxygen consumption,
local hypoxia and subsequently cell necrosis [28]. Perivas-
cular fibrosis was noted in 9% of cases (Fig. 4). This result
is in agreement with those of Karch who reported perivas-
cular fibrosis in a case of MA-related death. Perivascular fi-
brosis reduces myocardial flow reserve and possibly
generates myocardial infarction [12].
In accordance with previous research [2, 9], mild and
moderate to severe atherosclerosis was typically seen in
the coronary arteries. MA induces serotonin release
from nerve terminals and MA cardiotoxicity is held by
oxidative damage with underlying oxidative stress, con-
sequently it may have a key role in the pathophysiology
of atherosclerosis [33, 34]. In the present study three
cases showed acute myocardial infarction. Accelerated
atherosclerosis and rupture of preexisting atherosclerotic
plaques are some features inducing myocardial infarc-
tion in MA abusers [35]. Also Gao et al. reported that
chronic MA administration to animal models is accom-
panied by inflammation and atherosclerotic plaque for-
mation [36].
Moreover Hosseini-Sharifabad et al. in a study con-
ducted to evaluate the effect of ecstasy on mouse cardiac
histopathology found that increased levels of some neuro-
transmitters (serotonin, dopamine and norepinephrine)
can cause adverse cardiovascular effects [37].
Some of our findings do not support those of Islam et
al. in that; they found no histologic evidence of edema
and fibrosis in the cardiac tissue of rats treated with MA
[38]. However in the present study in pathologic exami-
nation enlarged, dilated ventricles and atria and conges-
tion were observed in 22% of cases. Several aspects may
help explain the discrepancy between results. Their re-
search was undertaken on experimental rat models and
our results obtained from human MA poisoning-related
death cases. They had used pure methamphetamine with
known doses to induce cardiac lesions, yet our study
cases had used different types of impure MA with un-
defined doses. The required and enough dose of MA for
producing cardiovascular complications or even death
are not clear. Not all people respond to a specific dose
of MA in the same manner due to interindividual varia-
tions in degree of tolerance and response to MA. There-
fore it is not reasonable to estimate MA toxicity based
on its dose [39]. Besides impurities in street drugs can
cause health hazards [7]. In Iran, street MA (Shishe) is
an impure cocktail of different chemicals originated from
manufacturing processes and other active pharmaceutical
ingredients with unknown doses [7, 40, 41]. In previous
studies conducted on street MA samples in Iran many im-
purities of origin such as N-acetylmethamphetamine, N,N-
dimethylamphetamine, phenmethrazine and benzaldehyde
were detected [7, 42, 43]. Cardiotoxic effects of phenmetra-
zine were discussed in previous studies. In severe poisoning
phenmetrazine causes cardiovascular collapse, myocardial
ischemia, ventricular dysfunction and infarction [7]. It
should be noted that none of the active pharmaceutical
Table 1 Major cardiac histopathology findings in
methamphetamine poisoning-related death cases (n = 100)
by light microscopy
Cardiac pathology feature Frequency
(%)
Mild atherosclerosis 22
Moderate to severe atherosclerosis 17
Congestion 22
Microscopic hemorrhage 7




Acute myocardial infarction 3
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ingredients other than methamphetamine and amphet-
amine were detected in biological samples in the present
study.
Intravenous drug abusers suffer from cardiac infec-
tions, endocarditis and pericarditis [42–44]. Although it
was reported that bacterial endocarditis and pericarditis
are rare [45], this study showed that one and four percent
of study cases had infective endocarditis and pericarditis
respectively. Besides mural endocardium thrombosis was
observed in combination with endocarditis. Illicit drugs
are produced in substandard conditions and diluted
several times along distribution lines by dealers. Bacterial
spores can be introduced into the drug during these pro-
cesses and cause infectious diseases such as endocarditis,
osteoarthritis and hepatitis [46, 47]. Tamizifar et al. re-
ported acute purulent pericarditis caused by Klebsiella
Pneumoniae in a 30-year old opioid abuser [48]. Pericardi-
tis due to Bacillus Cereus was reported in an IV drug user
[49]. MA injection is a new emerging health problem in
Iran. In a survey of 209 MA injection abusers, 47.4% re-
ported that they use sharing syringes when injecting MA
[4]. Therefore it is logical to see different results from
other studies due to higher prevalence of using common
syringes for injecting drugs.
The present study is limited in several ways. Dose and
type of abused MA was not known and unequal in all of
the cases. Duration and history of substance abuse habit
were not defined. However as cardiovascular complica-
tions in MA abusers can be produced in low doses, this
limitation did not overshadow our main purpose. A large
number of samples were excluded from the study as a
result of the positive outcomes obtained at toxicologic
examination for other drugs and abused substances
(opium alkaloids, methadone, tramadol and ethanol).
The other limitation of course is the lack of knowledge
of previous drug use.
Conclusion
There is growing body of evidence that MA abuse can
cause major health problems in vital organs and conse-
quently death. Mild, moderate-severe hypertrophy, myo-
cardial fiber hypertrophy and other cardiac pathology
features were observed in MA-related deaths irrespective
of age, sex and BMI. This recognition may prove to be
of some forensic value to clarify the cause of death in
MA abusers.
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